HUM vs TMO
Humana Inc (HUM) versus Thermo Fisher Scientific Inc (TMO) — a side-by-side from cached financials, not a winner call.
Humana Inc (HUM) is a healthcare plans company listed on NYSE.
Thermo Fisher Scientific Inc (TMO) is a diagnostics & research company listed on US.
Latest reported HUM revenue for 2024-12-31 was $117.76B. Net income was $1.21B. Revenue was up 10.7% from 2023-12-31 to 2024-12-31. HUM currently screens at market cap $43.46B and trailing P/E 38.6.
Latest reported TMO revenue for 2025-12-31 was $44.56B. Net income was $6.70B. Revenue was up 3.9% from 2024-12-31 to 2025-12-31. TMO currently screens at market cap $153.06B and trailing P/E 23.8.
HUM currently screens at market cap $43.46B and trailing P/E 38.6. TMO currently screens at market cap $153.06B and trailing P/E 23.8.
Not investment advice. Open the HUM and TMO stock pages for the full models.
Not investment advice.